Enlivex Therapeutics raised 212 million dollars.

Enlivex Therapeutics is Raising Investment

Enlivex Therapeutics is raising 212 million dollars for investment in a token called RAIN. This token supports a decentralized protocol used to create and trade prediction markets based on real-world events. The funds raised aim to serve as Enlivex's primary treasury reserve asset.

It has been stated that the investment will not affect the clinical trials of Allocetra, Enlivex's leading drug candidate. Additionally, as a result of the investment, former Italian Prime Minister Matteo Renzi will join the company's board of directors.